Asset Allocation

As of February 28, 2026.
Type % Net
Cash 14.17%
Stock 26.36%
Bond 53.61%
Convertible 0.00%
Preferred 0.00%
Other 5.86%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 80.80%    % Emerging Markets: 0.07%    % Unidentified Markets: 19.13%

Americas 80.32%
79.40%
Canada 0.26%
United States 79.14%
0.92%
Colombia 0.01%
As of February 28, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 0.50%
United Kingdom 0.17%
0.31%
Belgium 0.00%
France 0.03%
Ireland 0.08%
Italy 0.01%
Sweden 0.00%
Switzerland 0.13%
0.00%
0.02%
Israel 0.02%
United Arab Emirates 0.00%
Greater Asia 0.05%
Japan 0.00%
0.00%
Australia 0.00%
0.05%
Singapore 0.05%
0.00%
Unidentified Region 19.13%

Bond Credit Quality Exposure

AAA 0.00%
AA 0.00%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 100.0%
Short Term 0.00%
As of February 28, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
35.54%
Materials
4.98%
Consumer Discretionary
8.86%
Financials
16.54%
Real Estate
5.15%
Sensitive
41.41%
Communication Services
2.56%
Energy
5.94%
Industrials
18.68%
Information Technology
14.24%
Defensive
22.20%
Consumer Staples
1.94%
Health Care
17.24%
Utilities
3.01%
Not Classified
0.85%
Non Classified Equity
0.54%
Not Classified - Non Equity
0.31%
As of February 28, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of February 28, 2026
Type % Net
Government 100.00%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
100.0%
Less than 1 Year
100.0%
Intermediate
0.00%
1 to 3 Years
0.00%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of February 28, 2026
View Bond Maturity Exposure
Start Trial